Claims for Patent: 5,744,300

Summary for Patent: 5,744,300

Title:	Methods and reagents for the identification and regulation of senescence-related genes
Abstract:	Identification of senescence-related genes can be accomplished by comparing mRNA expression between young and senescent cells. Probes complementary to such genes can be used to detect senescent cells and distinguish between young and senescent cells as well as in screens to identify compounds that alter expression levels of senescence-related genes.
Inventor(s):	Linskens; Maarten H. K. (Palo Alto, CA), Hirsch; Kenneth S. (Palo Alto, CA), Villeponteau; Bryant (San Carlos, CA), Feng; Junli (San Carlos, CA), Funk; Walter (Union City, CA), West; Michael David (Belmont, CA)
Assignee:	Geron Corporation (Menlo Park, CA)
Application Number:	08/332,420
Patent Claims:	1. A method of screening to identify one or more test compounds that can alter gene expression in senescent cells, which method comprises: (a) contacting senescent cells with test compound; (b) determining mRNA expression patterns in said senescent cells by determining expression levels of mRNA of two or more senescence-related genes; and (c) correlating an alteration in mRNA expression of two or more senescent related genes in said senescent cells with a compound that can alter gene expression in a senescent cell. 2. The method of claim 1, wherein said senescence-related genes comprise genetags selected from the group consisting of 00C2, 00K1, 01C1, 01D1, 01E4, 01M4, 01M5, 02A2, 02C1, 05J2, 06E1, 07E1, 07J1, 08D5, 08E3, 08F1, 09E2, 10D1, 11E1, 12F2, 16C1, 16C2, 16F2, 16F3, 17M1, 18C1, and 18M3. 3. The method of 1, claim wherein said test compounds have, prior to step (a), been tested for their ability to modulate activity or expression levels of a first senescence-related gene product and determined to have said ability. 4. The method of claim 1, wherein step (b) comprises determining expression levels of mRNA of at least two but less than five senescence-related genes. 5. The method of 1, wherein step (b) comprises determining expression levels of MRNA of at least five but less than ten senescence-related genes. 6. The method of claim 1, wherein step (b) comprises determining expression levels of MRNA of at least ten but less than twenty senescence-related genes. 7. The method of claim 3, wherein said first senescence-related gene product is beta-galactosidase. 8. The method of claim 3, wherein said first senescence-related gene product is collagenase. 9. The method of claim 3, wherein said first senescence-related gene product is IFN gamma. 10. A method according to claim 1, wherein alteration of mRNA expression of senescence-related genes is detected by nucleic acid hybridization. 11. A method according to claim 1 wherein detection is by Northern analysis. 12. A method according to claim 1 wherein alteration of mRNA expression of senescence-related genes is detected by analysis of expression of mRNAs comprising genetags specific for said senescence-related genes. 13. A method according to claim 1 wherein the test compound is a synthetic organic compound. 14. A method according to claim 1 wherein the test compound is a natural product. 15. A method according to claim 1, wherein the test compound is a peptide. 16. A method according to claim 1, wherein the test compound is an oligonucleotide. 17. A method according to claim 1, which is a high throughput screening method.

Details for Patent 5,744,300

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-02-26